|
1
|
Lambert R and Hainaut P: The
multidisciplinary management of gastrointestinal cancer.
Epidemiology of oesophagogastric cancer. Best Pract Res Clin
Gastroenterol. 21:921–945. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guohong Z, Min S, Duenmei W, Songnian H,
Min L, Jinsong L, Hongbin L, Feng Z, Dongping T, Heling Y, et al:
Genetic heterogeneity of oesophageal cancer in high-incidence areas
of southern and northern China. PLoS One. 5:e96682010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Meeusen B and Janssens V: Tumor
suppressive protein phosphatases in human cancer: Emerging targets
for therapeutic intervention and tumor stratification. Int J
Biochem Cell Biol. 96:98–134. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Elson A: Stepping out of the shadows:
Oncogenic and tumor-promoting protein tyrosine phosphatases. Int J
Biochem Cell Biol. 96:135–147. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tonks NK: Protein tyrosine
phosphatases-from housekeeping enzymes to master regulators of
signal transduction. FEBS J. 280:346–378. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kleppe M, Soulier J, Asnafi V, Mentens N,
Hornakova T, Knoops L, Constantinescu S, Sigaux F, Meijerink JP,
Vandenberghe P, et al: PTPN2 negatively regulates oncogenic JAK1 in
T-cell acute lymphoblastic leukemia. Blood. 117:7090–7098. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Plutzky J, Neel BG, Rosenberg RD, Eddy RL,
Byers MG, Jani-Sait S and Shows TB: Chromosomal localization of an
SH2-containing tyrosine phosphatase (PTPN6). Genomics. 13:869–872.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Oka T, Yoshino T, Hayashi K, Ohara N,
Nakanishi T, Yamaai Y, Hiraki A, Sogawa CA, Kondo E, Teramoto N, et
al: Reduction of hematopoietic cell-specific tyrosine phosphatase
SHP-1 gene expression in natural killer cell lymphoma and various
types of lymphomas/leukemias: Combination analysis with cDNA
expression array and tissue microarray. Am J Pathol. 159:1495–1505.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chim CS, Fung TK, Cheung WC, Liang R and
Kwong YL: SOCS1 and SHP1 hypermethylation in multiple
myeloma: Implications for epigenetic activation of the Jak/STAT
pathway. Blood. 103:4630–4635. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Amin HM, Hoshino K, Yang H, Lin Q, Lai R
and Garcia-Manero G: Decreased expression level of SH2
domain-containing protein tyrosine phosphatase-1 (Shp1) is
associated with progression of chronic myeloid leukaemia. J Pathol.
212:402–410. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Challouf S, Ziadi S, Zaghdoudi R, Ksiaa F,
Ben Gacem R and Trimeche M: Patterns of aberrant DNA
hypermethylation in nasopharyngeal carcinoma in Tunisian patients.
Clin Chim Acta. 413:795–802. 2010. View Article : Google Scholar
|
|
14
|
Hachana M, Trimeche M, Ziadi S, Amara K
and Korbi S: Evidence for a role of the Simian Virus 40 in human
breast carcinomas. Breast Cancer Res Treat. 113:43–58. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Banville D, Stocco R and Shen SH: Human
protein tyrosine phosphatase 1C (PTPN6) gene structure: Alternate
promoter usage and exon skipping generate multiple transcripts.
Genomics. 27:165–173. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tsui FW, Martin A, Wang J and Tsui HW:
Investigations into the regulation and function of the SH2
domain-containing protein-tyrosine phosphatase, SHP-1. Immunol Res.
35:127–136. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yamasaki M, Miyata H, Miyazaki Y,
Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M and Doki
Y: Evaluation of the nodal status in the 7th edition of the
UICC-TNM classification for esophageal squamous cell carcinoma:
Proposed modifications for improved survival stratification: Impact
of lymph node metastases on overall survival after esophagectomy.
Ann Surg Oncol. 21:2850–2856. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Warnecke PM and Bestor TH: Cytosine
methylation and human cancer. Curr Opin Oncol. 12:68–73. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Parris TZ, Kovács A, Hajizadeh S, Nemes S,
Semaan M, Levin M, Karlsson P and Helou K: Frequent MYC
coamplification and DNA hypomethylation of multiple genes on 8q in
8p11-p12-amplified breast carcinomas. Oncogenesis. 3:e952014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vasiljević N, Scibior-Bentkowska D,
Brentnall AR, Cuzick J and Lorincz AT: Credentialing of DNA
methylation assays for human genes as diagnostic biomarkers of
cervical intraepithelial neoplasia in high-risk HPV positive women.
Gynecol Oncol. 132:709–714. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
El-Osta A, Baker EK and Wolffe AP:
Profiling methyl-CpG specific determinants on transcriptionally
silent chromatin. Mol Biol Rep. 28:209–215. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Oka T, Ouchida M, Koyama M, Ogama Y,
Takada S, Nakatani Y, Tanaka T, Yoshino T, Hayashi K, Ohara N, et
al: Gene silencing of the tyrosine phosphatase SHP1 gene by
aberrant methylation in leukemias/lymphomas. Cancer Res.
62:6390–6394. 2002.PubMed/NCBI
|
|
24
|
Chim CS, Wong KY, Loong F and Srivastava
G: SOCS1 and SHP1 hypermethylation in mantle cell
lymphoma and follicular lymphoma: Implications for epigenetic
activation of the Jak/STAT pathway. Leukemia. 18:356–358. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sheng Y, Wang H, Liu D and Zhang C, Deng
Y, Yang F, Zhang T and Zhang C: Methylation of tumor suppressor
gene CDH13 and SHP1 promoters and their epigenetic regulation by
the UHRF1/PRMT5 complex in endometrial carcinoma. Gynecol Oncol.
140:145–151. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang MY, Fung TK, Chen FY and Chim CS:
Methylation profiling of SOCS1, SOCS2, SOCS3, CISH and
SHP1 in Philadelphia-negative myeloproliferative neoplasm. J
Cell Mol Med. 17:1282–1290. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Han Y, Amin HM, Frantz C, Franko B, Lee J,
Lin Q and Lai R: Restoration of shp1 expression by
5-AZA-2′-deoxycytidine is associated with downregulation of
JAK3/STAT3 signaling in ALK-positive anaplastic large cell
lymphoma. Leukemia. 20:1602–1609. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Niwa Y, Kanda H, Shikauchi Y, Saiura A,
Matsubara K, Kitagawa T, Yamamoto J, Kubo T and Yoshikawa H:
Methylation silencing of SOCS-3 promotes cell growth and migration
by enhancing JAK/STAT and FAK signalings in human hepatocellular
carcinoma. Oncogene. 24:6406–6417. 2005. View Article : Google Scholar : PubMed/NCBI
|
